An introduction to peptide synthesis, chemistry manufacturing and controls (CMC), and the key quality concepts behind pharmaceutical peptide production.
Filed under manufacturing testing, written for pharmacist-compounder, researcher, founder-operator, regulator-compliance.
Not medically reviewed. Last updated 2026-04-05. Nothing here is medical advice.
Understanding how peptides are manufactured provides important context for evaluating product quality and regulatory compliance.
The dominant method for manufacturing synthetic peptides is solid-phase peptide synthesis, developed by Bruce Merrifield (Nobel Prize, 1984). SPPS builds peptides one amino acid at a time on a solid resin support, allowing for automated production and purification.
CMC refers to the regulatory documentation describing how a drug is manufactured, tested, and controlled. For peptide drugs, CMC includes:
Pharmaceutical-grade peptides must be manufactured under GMP conditions, which include:
This article provides manufacturing education for industry professionals and does not evaluate specific manufacturers.
More guides: All guides, Safety centre, Peptide library.